Preventing ovarian cancer through genetic testing: A population-based study

Clinical Genetics

Volumn 86, Issue 5, 2014, Pages 496-499

  Finch, A ^a   Bacopulos, S ^a   Rosen, B ^a   Fan, I ^b   Bradley, L ^b   Risch, H ^c   Mclaughlin, J R ^d   Lerner Ellis, J ^b,e,f   Narod, S A ^a  

^a UNIVERSITY OF TORONTO   (Canada)

^b MOUNT SINAI HOSPITAL   (Canada)

^c YALE UNIVERSITY   (United States)

^d PUBLIC HEALTH ONTARIO   (Canada)

^e UNIVERSITY OF TORONTO   (Canada)

^f ONTARIO INSTITUTE FOR CANCER RESEARCH   (Canada)

Author keywords

BRCA1; BRCA2; Ovarian cancer; Personalized medicine

Indexed keywords

ADULT; AGED; ARTICLE; BLOOD SAMPLING; CANADA; CANCER PREVENTION; CANCER RISK; CARCINOGENESIS; COPY NUMBER VARIATION; FEMALE; GENE MUTATION; GENETIC ANALYSIS; GENETIC SCREENING; GENETIC SUSCEPTIBILITY; HUMAN; MAJOR CLINICAL STUDY; OVARY CANCER; PEDIGREE; PERSONALIZED MEDICINE; POPULATION RESEARCH; TUMOR SUPPRESSOR GENE; GENETIC PREDISPOSITION; GENETICS; MIDDLE AGED; MUTATION; OVARIAN NEOPLASMS; POPULATION GENETICS; PROCEDURES; RISK FACTOR; YOUNG ADULT;

ADULT; AGED; FEMALE; GENES, BRCA1; GENES, BRCA2; GENETIC PREDISPOSITION TO DISEASE; GENETIC TESTING; GENETICS, POPULATION; HUMANS; MIDDLE AGED; MUTATION; OVARIAN NEOPLASMS; RISK FACTORS; YOUNG ADULT;

EID: 84911950632     PISSN: 00099163     EISSN: 13990004     Source Type: Journal    
DOI: 10.1111/cge.12313     Document Type: Article

References (7)

1. Metcalfe KA, Mian N, Enmore M et al. Long-term follow-up of Jewish women with a BRCA1 and BRCA2 mutation who underwent population genetic screening. Breast Cancer Res Treat 2012: 133: 735-740.
2. Finch A, Beiner M, Lubinski J et al. Salpingo-oophorectomy and the risk of ovarian, fallopian tube, and peritoneal cancers in women with a BRCA1 or BRCA2 mutation. JAMA 2006: 296: 185-192.
3. Rebbeck TR, Kauff ND, Domchek SM. Meta-analysis of risk reduction estimates associated with risk-reducing salpingo-oophorectomy in BRCA1 or BRCA2 mutation carriers. J Natl Cancer Inst 2009: 101: 80-87.
4. Zhang S, Royer R, Li S et al. Frequencies of BRCA1 and BRCA2 mutations among 1, 342 unselected patients with invasive ovarian cancer. Gynecol Oncol 2011: 121: 353-357.
5. Metcalfe KA, Fan I, McLaughlin J et al. Uptake of clinical genetic testing for ovarian cancer in Ontario: a population-based study. Gynecol Oncol 2009: 112: 68-72.
6. Walsh T, Casadei S, Lee MK et al. Mutations in 12 genes for inherited ovarian, fallopian tube, and peritoneal carcinoma identified by massively parallel sequencing. Proc Natl Acad Sci USA 2011: 108: 18032-18037.
7. Ruark E, Snape K, Humburg P et al. Mosaic PPM1D mutations are associated with predisposition to breast and ovarian cancer. Nature 2013: 493: 406-410.